A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India

Sponsor
Asian Institute of Gastroenterology, India
Study ID
NCT07486518
Status
Recruiting
Apply to this trial

Conditions

  • Early Gastric Cancer
  • Gastric Adenocarcinoma

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Accepted

Study Details

To estimate the prevalence of histologically confirmed early gastric cancer (EGC) in an Indian multicentre cohort undergoing standardised high-quality upper gastrointestinal endoscopy. EGC is defined as gastric adenocarcinoma confined to the mucosa or submucosa (T1), irrespective of lymph node status, based on histopathology.

Key Dates

First listed
Mar 20, 2026
Start date
Aug 1, 2026
Status verified
Jun 2026
Primary completion
Apr 1, 2028
Completion
Jul 1, 2028

Study Design

Enrollment
4,000 participants (estimated)

Primary Outcome Measure

Prevalence of histologically confirmed early gastric cancer [ Time Frame: 2 years ]

Central Contacts

Related Studies